The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction

Cited by (223)

Items 201–223 of 223

1. Additional file 1 of Myocardial fat accumulation is associated with cardiac dysfunction in patients with type 2 diabetes, especially in elderly or female patients: a retrospective observational study
   Risa Kashiwagi-Takayama, Kozawa, Junji, Yoshiya Hosokawa, Sarasa Kato, Satoshi Kawata, Harutoshi Ozawa, Ryohei Mineo, Ishibashi, Chisaki, Megu Yamaguchi Baden, Ryuya Iwamoto et al. · 2023 · Figshare
2. Additional file 1 of Evidence that tirzepatide protects against diabetes-related cardiac damages
   Fatemeh Taktaz, Lucia Scisciola, Rosaria Anna Fontanella, Ada Pesapane, Puja Ghosh, Martina Franzese, Tortorella, Giovanni, Armando Puocci, Eduardo Sommella, Giuseppe Signoriello et al. · 2024 · Figshare
3. Preventive effect of liraglutide on postoperative delirium in elderly patients undergoing cardiac surgery: protocol for a single-centre, randomised, double-blind, placebo-controlled trial
   Shengwei Bai, Ming Wei, Ying Wu, Xuewen Zhu, Z Q Wang, Yan Wang, Cuicui Zhu, Yan Guan, Dongjin Wang, Wenxue Liu · 2026 · BMJ Open
4. Efficacy and Safety of Dapagliflozin in Patients Over 75 Years Old With Heart Failure With Preserved Ejection Fraction: A Retrospective Study
   Juan Wang, Zhanliang Li, Guiyue Zhu · 2026 · British Journal of Hospital Medicine
5. Empagliflozin protects against acute myocardial infarction by modulating the mTORC1–S6K pathway to drive metabolic reprogramming
   Bo Zhang (6559), Jinbing Xing, Bin Li, Zhuo Zhao · 2026 · Journal of Radiation Research and Applied Sciences
6. Efficacy comparison of dapagliflozin combined with liraglutide versus monotherapy in obese patients with heart failure
   Guangzhi Zhou, Aijun Liu, Xiabing Hu, Guangdong Qi, Yonglin Zhang · 2026 · Medicine
7. Rôle des péricytes et des cellules endothéliales dans l'insuffisance cardiaque
   Lauriane Cornuault · 2022 · theses.fr (ABES)
8. Senescence and DNA Damage–Induced Inflammation Drive Heart Failure with Preserved Ejection Fraction in Cardiovascular Kidney Metabolic Syndrome
   Dao‐Fu Dai, Jun‐yi Zhu, Meng Qiu Gao, Kaihao Wang, Nastaran Daneshgar, Xiaoping Yang, Virginia Shalkey Hahn, Monica Vladut Talor, Daniela Čiháková, Avi Z. Rosenberg et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
9. Targeting the ALCAT1 enzyme for the treatment of pressure-overload hypertrophy
   Youhua Wang, Dandan Jia, Yuguang Shi · 2026 · Cardiovascular Research
10. Cardiac GLP1R gene expression: A cross-species single-cell transcriptomic analysis
    Christopher Dostal, Matthias Ernst, Johanna Reiner, Ryan Snelling, Chenming Hu, Péter Pokreisz, Attila Kiss, Bruno Karl Podesser · 2026 · Advances in Translational Research
11. Selective loss of Cx40 and conduction abnormalities underlie enhanced atrial fibrillation susceptibility in a HFpEF model in male mice
    Kohei Kawajiri, Satoshi Iwamiya, Leo Yaga, Masahiro Yamazoe, Kensuke Ihara, Yurie Soejima, Tetsuo Sasano · 2026 · Physiological Reports
12. Estrogen-Deficiency Degrades Left Ventricular Diastolic Function and Energy Metabolism in Hypertensive Female Mice
    Aijun Zhang, Shumin Li, Indira Vedula, Somik Chatterjee, Yang Wu, Jianhua Gu, George Gerald Rodney, Karla Marie Kurrelmeyer, Heinrich Taegtmeyer, Dale J. Hamilton et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
13. AGONISTAS DO GLP-1 E INSUFICIÊNCIA CARDÍACA: EVIDÊNCIAS DA RELAÇÃO TERAPÊUTICA
    Verônica Cristina Carvalho Chaves, Amanda Gêa Gomes Gonçalves, Gabriel Baiocchi Vieira Nascimento, Giovana Pezzini Backes, Maria Paula Maciel Bomtempo, Mireli Lacerda Borges, PIETRA SANTOS VIANA, Sarah Matias Moreira, Victor Hugo Oliveira Moraes, Sofia Reis de Oliveira Crispim · 2026 · Revista Foco
14. Liraglutide combined with dapagliflozin treatment improves myocardial disease and endothelial dysfunction in T2DM mice
    Anjun Tan, Tian‐Rong Li, Jing‐Jing Yang, Xiaolu Li, Wen-Qin Li, Jinwen Yu · 2026 · Journal of Diabetes Investigation
15. AGONISTAS DO GLP-1 E INSUFICIÊNCIA CARDÍACA: EVIDÊNCIAS DA RELAÇÃO TERAPÊUTICA
    Verônica Cristina Carvalho Chaves, Amanda Gêa Gomes Gonçalves, Gabriel Baiocchi Vieira Nascimento, Giovana Pezzini Backes, Maria Paula Maciel Bomtempo, Mireli Lacerda Borges, PIETRA SANTOS VIANA, Sarah Matias Moreira, Victor Hugo Oliveira Moraes · 2026 · Revista Contemporânea
16. Metabolic Dysfunction–Associated Steatotic Liver Disease as a Systemic Driver of Heart Failure With Preserved Ejection Fraction: Mechanistic Insights and Emerging Therapeutic Perspectives
    Junli Wu, Wenwen Zheng, Qianxian Qi, Chao‐Jie He, Changlin Zhai, Hongyan Fan · 2026 · Reviews in Cardiovascular Medicine
17. Dapagliflozin Attenuates Pericardial Adipose Tissue–Derived Leptin‐Mediated Myocardial Remodeling in Obese Rats
    Chaodi Luo, Wenjie Luo, Tingting Zheng, Ping Wang, Lifei Cao, Hui Luan, Yan Song, X B Li, Gang Tian · 2026 · Journal of the American Heart Association
18. Advances in Cardiovascular Pharmacotherapy. X. Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure and Mechanisms of Protection
    Paul S. Pagel, Dustin Hang, Julie K. Freed, George J. Crystal · 2026 · Journal of Cardiothoracic and Vascular Anesthesia
19. Glucagon-like peptide-1 receptor agonists and the risk of ventricular arrhythmia in patients with acute myocardial infarction and type 2 diabetes mellitus: a propensity score-matched cohort study
    Chunqin Hu, Wenming Zhao, Shasha Xiao, Jiujiu Shi, Wenhua Liang, Ruiwei Guo · 2026 · BMC Cardiovascular Disorders
20. Cardiometabolic stress induces HFpEF with impaired bioenergetics and disrupted proteostasis in aged female mice
    Kamil Aleksander Kobak, Weronika Zarzycka, Catherine J. King, Frederick F. Peelor, Charlie Burnett, Willard M. Freeman, Kenneth Michael Humphries, Benjamin F. Miller, Ying Ann Chiao · 2026 · Journal of Molecular and Cellular Cardiology
21. Skeletal Muscle Dysfunction in Heart Failure
    Azariyas A. Challa, Ambarish Pandey, P H. Brubaker, Dalane W. Kitzman, Biykem Bozkurt, Dinesh K. Kalra · 2026 · JACC Heart Failure
22. Impaired mitochondrial proteostasis underlies cardiomyocyte bioenergetic dysfunction in a murine three-hit model of heart failure with preserved ejection fraction
    Xuan Li, Yiling Fu, Jussara Marcia do Carmo, Alexandre A. da Silva, Alan J. Mouton, Ana Carolina Mieko Omoto, Lucas Wang, John Edward Hall, Zhen Wang · 2026 · American Journal of Physiology-Heart and Circulatory Physiology
23. Artificial intelligence-enabled deep clinical phenotyping in heart failure with preserved ejection fraction: from patient subtypes to precision care
    Francisco Epelde · 2026 · Frontiers in Cardiovascular Medicine